A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors
Clinical trial NCT04157517 · TERMINATED
Trial details
- NCT number
- NCT04157517
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-12
- Primary completion
- 2023-12-20
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.